J
John F. Forbes
Researcher at University of Limerick
Publications - 373
Citations - 51254
John F. Forbes is an academic researcher from University of Limerick. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 88, co-authored 368 publications receiving 46433 citations. Previous affiliations of John F. Forbes include University of Newcastle & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Which stroke patients gain most from intermittent pneumatic compression: further analyses of the CLOTS 3 trial
TL;DR: It seems reasonable to recommend that IPC should be considered in all immobile acute stroke patients, but that the final decision should be based on a judgment about the individual's prognosis, other than the fifth with the best prognosis.
Journal ArticleDOI
An evaluation of community antenatal care
TL;DR: A study to ascertain how the community based antenatal services in the East End of Glasgow related to the guidelines set by a Working Party on Ante-Natal and Intrapartum Care (Royal College of Obstetricians and Gynaecologists, 1982) is reported.
Journal ArticleDOI
Neoadjuvant chemotherapy with sequential anthracycline–docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
Nicole McCarthy,Nicole McCarthy,Frances M. Boyle,Frances M. Boyle,Nicholas Zdenkowski,James M. Bull,Eugene Leong,Andrew Simpson,George Kannourakis,Prudence A. Francis,Prudence A. Francis,Jacquie Chirgwin,E Abdi,Val Gebski,Anne-Sophie Veillard,Diana Zannino,Nicholas Wilcken,Linda Reaby,Dianne F Lindsay,Heath Badger,John F. Forbes +20 more
TL;DR: Neoadjuvant gemcitabine, when added to docetaxel, after epirubicin and cyclophosphamide, did not reach the pre-specified expectations for pCR rate in HER2-negative tumours, and cannot be recommended.